Le Lézard
Classified in: Health
Subjects: SVY, CSR, ANW

Elanco Releases First-Ever Corporate Social Responsibility Impact Report


GREENFIELD, Ind., June 12, 2017 /PRNewswire/ -- Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), today released its inaugural global Corporate Social Responsibility (CSR) Impact Report demonstrating its commitment to impact food security and the support of the human-animal bond.

Elanco Releases Corporate Social Responsibility Impact Report

The Impact Report is available at Elanco.com on the Giving Back section of the website.

"Elanco's vision of Food and Companionship Enriching Life isn't just a phrase that lives on a plaque, it lives in the hearts and minds of our employees," said Simmons, president, Elanco. "Our causes ? food security and the human-animal bond ? are at the heart of our culture. Our employees tell us they are inspired by seeing the greater picture of how their work contributes to the long-term improvement of others' lives."

Elanco's cause-driven efforts are centered on three key areas: employee volunteerism, community and customer engagement, and global sustainable development. By 2020, Elanco's goal are to complete 200,000 volunteer hours, ensure 100 communities are food secure, and engage in 10 global sustainable development projects. Results of our work over the last few years include:

Global employee volunteerism

Community and customer engagement

Global sustainable development

"In this first social impact report, we share our strategy, but most importantly, the impact of how we are enriching lives across the globe," Simmons said. "We are excited to see progress against our goals, but we know that we are just getting started."

About Elanco
Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at Elanco.com.

 

Elanco 2-D logo

SOURCE Elanco


These press releases may also interest you

at 18:55
ZYUS Life Sciences Corporation ("ZYUS" or the "Company") is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May...

at 18:42
George Weston Limited ("Weston" or the "Company") today announced that all of the nominee directors listed in its management proxy circular dated March 19, 2024, were elected as directors of the Company. The vote was conducted at the Company's...

at 18:41
Family Source Consultants, LLC, a leading provider of surrogacy, egg donation, and all third-party reproduction services, is excited to announce the grand opening of its new state-of-the-art office dedicated to enhancing the journeys of intended...

at 18:15
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024....

at 18:00
In recognition of Mother's Day on May 12th, Denny's Canada is delighted to announce that they have partnered with Women's Health Collective Canada (WHCC) to host a special fundraiser. From May 7th to 12th, in participating stores across Canada, $2...

at 17:41
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial...



News published on and distributed by: